| 논문분류 | 춘계학술대회 초록집 |
|---|---|
| 제목 | Nephrotic Syndrome Associated with Graft Versus Host Disease Following Allogenic Hematopoietic Stem Cell Transplantation |
| 저자 | Yul Hee Cho1, Seok Hui Kang2, Myung Hyun Lee1, Gun Hee An1, Byung Ha Chung1, Bum Soon Choi1, Chul Woo Yang1, Yong-soo Kim1, Yeong Jin Choi3, Cheol Whee Park1 |
| 출판정보 | 2013; 2013(1): |
| 키워드 | 조혈모세포이식, 신증후군, 단백뇨/ HSCT, Nephrotic syndrome, Proteinuria |
| 초록 | Backgroud: Hematopoietic stem cell transplantation (HSCT) is an effective therapy for diseases requiring strong chemotherapy. Renal manifestation in chronic graft-versus-host disease (GVHD), presenting as nephritic syndrome (NS), has been reported. Previous studies associated with NS after allogeneic HSCT has only been reported as isolated case report or small studies. More cases about this help us understand about the pathogenesis and incidence of renal NS after HSCT. Patients and methods: Between Janary 2000 and January 2013, we reviewed the renal pathology archives at Seoul and Yeouido St. Mary’s Hospital in Korea and identified 15 patients who had biopsy-proven nephropathy after allogeneic HSCT. Results: Of these patients, all patients had chronic GVHD. The commonest indication of biopsy was proteinuria, found in all patients including 8 in the nephrotic range proteinuria. Most common pathologic findings was membranous nephropathy (MN, n=12) and other glomerular disease included membranous proliferative glomerulonephritis, C1q nephropathy, and diabetic nephropathy. Among them, 9 patients were not treated with immunosuppressive agent at the time of biopsy. Of these 15 patients, 11 patients were treated with starting or intensification of immunosuppressive agent and 3 patients were treated with only angiotensin II receptor blocker (ARB). Overall response rate including complete remission and partial remission was 73%. Response for treatment were categorized as complete remission (CR), partial remission (PR) or non-response (NR). CR and PR were defined as reduction of proteinuria less than 0.2 g/day and between 0.21 g/day and 3.4 g/day, respectively. 2 patients remained non-responder. Conclusion: This study collects 15 renal biopsies from 15 patients, the largest clinicopathologic study of biopsy-proven nephropathy after HSCT in literature. Most of them responsed to immunosuppressions. Considering a growing population of long-term survival after allo-HSCT, renal biopsies are essential to diagnosis the underlying cause of renal dysfunction. Proper management according to definite diagnosis can prevent renal progression. |
| 원문(PDF) | PDF 원문보기 |